Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02159300 · ClinicalTrials.gov registry record

Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study

A clinical trial, sponsored by NYU Langone Health.

Completed
Registry status
40
Enrollment target

NCT02159300: Completed study, sponsored by NYU Langone Health.

NCT02159300 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02159300 has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
40 participants
Enrollment target

Study Summary

The long-term purpose of the investigator's research is to understand the pathophysiological basis of chronic pain. This will help provide a framework for the development of effective treatments. The purpose of this specific study is to find if there are abnormal brain rhythms in patients with fibromyalgia syndrome (FM) who are in pain since this will indicate particular types of treatments. FM is a disorder of the muscles and/or joints, and patients experience sever fatigue. FM occurs more often in women than in men (3.4% of women, 0.5% of men). The diseases can appear at any age, but in most of the cases it occurs in women of childbearing age. FM is considered a chronic pain condition since the pain is persistent. Pain and tenderness can be widespread throughout the body. FM patients are more sensitive to sound and pressure stimulation than healthy controls, indicating that there may be changes in the brain. Also, pain is made worse under conditions of stress. Treatments for FM pain include life style changes such as exercise, dietary changes, cognitive-behavioral therapy, medications and even surgery, but there is no accepted "best" treatment. This is partly because the underlying cause of the pain is not well understood. The design of this study is to record brain activity to find if there are abnormal brain rhythms in people with FM that are not present in healthy adults of the same age. Specifically, the investigators will test the hypothesis that constant low frequency oscillations will be present in patients with chronic pain due to FM. This has been found in people with other types of pain and is called Thalamocortical Dysrhythmia (TCD). The study has two parts. In the first part, a complete medical history will be obtained, including a description of the person's pain. In the second part the investigators will use magnetoencephalography (MEG) to non-invasively record brain activity. The MEG data will be analyzed in terms the presence of normal alpha rhy

Primary Outcome

The power of brain activity in the delta, theta, alpha, beta and gamma frequency ranges.

Interventions

  • BEHAVIORAL experience brain activity recording

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2010-12
Est. Completion 2015-06
NYU Langone Health

1,164 total trials

What the finished NCT02159300 record still lists

NCT02159300 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which experience brain activity recording is the first listed.

NCT02159300 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02159300 about?

NCT02159300 is a clinical study titled "Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study". The long-term purpose of the investigator's research is to understand the pathophysiological basis of chronic pain. This will help provide a framework for the development of effective treatments. The purpose of this specific study is to find if there are abnormal brain rhythms in patients with fibro...

What is the current status of trial NCT02159300?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2010-12. Estimated completion is 2015-06.

What interventions are being tested in trial NCT02159300?

The interventions under investigation include: experience brain activity recording (BEHAVIORAL).

Who is sponsoring clinical trial NCT02159300?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02159300, the US trial registry maintained by the National Library of Medicine. NCT02159300 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.